Baseline characteristics of study respondents; Table 2b Glycemic control and hypoglycemia
| Category | All regions n (%) | North America n (%) | South America n (%) | Europe n (%) |
|---|---|---|---|---|
| Table 2a | ||||
| Clinical | ||||
| Male/female | 58.0% | 57.7 | 54.1% | 61.9% |
| Mean age (years) | 51.4 | 54.5 | 48.1 | 53.4 |
| Mean duration with diabetes (years) | 10.7 | 12.4 | 9.8 | 11.0 |
| Mean duration with insulin (years) | 5.7 | 6.4 | 4.8 | 6.3 |
| Mean BMI(kg/m2) | 30.3 | 33.5 | 29.1 | 30.3 |
| Live alone | 21.1% | 29.6% | 12.9% | 25.7% |
| Have children | 74.8% | 60.5% | 83.8% | 71.8% |
| Married or partnered | 68.7% | 62.7% | 68.1% | 71.6% |
| College/university degree | 46.1% | 44.1% | 52.0% | 41.2% |
| In paid employment or self-employed | 37.6% | 32.0% | 40.1% | 37.3% |
| Monthly household income before tax=<approximately ≤US$3 000 | 31.5%* | 32.8% | 28.0%* | 34.5%† |
| Type of insulin used | ||||
| Basal insulin only | 1841 (49.0%) | 274 (42.4%) | 963 (62.7%) | 604 (38.4%) |
| Bolus insulin only | 490 (13.0%) | 59 (9.1%) | 166 (10.8%) | 265 (16.8%) |
| Basal and bolus insulin | 1020 (27.1%) | 224 (34.7%) | 274 (17.8%) | 522 (33.1%) |
| Premixed only | 332 (8.8%) | 70 (10.8%) | 106 (6.9%) | 156 (9.9%) |
| Other combination | 75 (2.0%) | 19 (2.9%) | 28 (1.8%) | 28 (1.8%) |
| Payment of medication | ||||
| Yes, I pay for all of it | 657 (17.5%) | 123 (19.0%) | 391 (25.4%) | 143 (9.1%) |
| Yes, I pay for some of it | 1011 (26.9%) | 335 (51.9%) | 382 (24.9%) | 294 (18.7%) |
| No, I don't pay for any of it | 2090 (55.6%) | 188 (29.1%) | 764 (49.7%) | 1138 (72.3%) |
| Table 2b | ||||
| HbA1c | ||||
| HbA1c and patient awareness | ||||
| Number of respondents knowing their HbA1c | 2441 (65.0%) | 395 (61.2%) | 964 (62.7%) | 1082 (68.7%) |
| Respondents’ mean HbA1c | 67 mmol/mol (8.3%) | 63 mmol/mol (7.9%) | 75 mmol/mol (9.0%) | 64 mmol/mol (8.0%) |
| Number of respondents who are aware of target HbA1c | 2308 (61.4%) | 392 (60.7%) | 909 (59.1%) | 1007 (63.9%) |
| Hypoglycemic events | ||||
| Have respondents ever experienced a minor hypoglycemic event? | ||||
| Yes | 2950 (78.5%) | 500 (77.4%) | 1202 (78.3%) | 1248 (79.2%) |
| Frequency of minor hypoglycemic events | ||||
| 3 times weekly | 256 (8.7%) | 31 (6.2%) | 112 (9.3%) | 113 (9.1%) |
| Once weekly | 757 (25.7%) | 109 (21.8%) | 323 (26.9%) | 325 (26.0%) |
| Once monthly | 805 (27.3%) | 147 (29.4%) | 317 (26.4%) | 341 (27.3%) |
| Once every 3 months | 420 (14.2%) | 87 (17.4%) | 163 (13.6%) | 170 (13.6%) |
| Less than once every 3 months | 712 (24.1%) | 126 (25.2%) | 287 (23.9%) | 299 (24.0%) |
| Never | 710 (18.9%) | 119 (18.4%) | 294 (19.1%) | 297 (18.9%) |
| Mean number of events yearly | 25.0 | 20.8 | 26.2 | 25.5 |
| Have respondents ever experienced a major hypoglycemic event? | ||||
| Yes | 929 (24.7%) | 178 (27.6%) | 345 (22.5%) | 406 (25.8%) |
| Number of major hypoglycemic events during the past 12 months | ||||
| 0 | 2754 (73.3%) | 446 (69.0%) | 1148 (74.7%) | 1160 (73.7%) |
| 1–2 | 391 (10.4%) | 69 (10.7%) | 137 (8.9%) | 185 (11.7%) |
| 3–4 | 166 (4.4%) | 44 (6.8%) | 47 (3.1%) | 75 (4.8%) |
| 5–6 | 75 (2.0%) | 13 (2.0%) | 23 (1.5%) | 39 (2.5%) |
| 7–8 | 24 (0.6%) | 8 (1.2%) | 4 (0.3%) | 12 (0.8%) |
| 9–10 | 49 (1.3%) | 9 (1.4%) | 21 (1.4%) | 19 (1.2%) |
| More than 10 | 108 (2.9%) | 14 (2.2%) | 60 (3.9%) | 34 (2.2%) |
*The number for South America is an estimate, since different country-specific currencies were used.
†The value for Europe is based on the % of respondents with a monthly household income of ≤€1999.
BMI, body mass index; HbA1c, glycated hemoglobin level.